Worth reading
53Recurring
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
6
Approximately ¥ million (transferred assets)Wording
Avoiding a definitive answer
How definitive the wording is.This transaction
This absorption-type company split (business acquisition)Counterparty (target company)ポポヤクコーポレーション株式会社
Disclosing companyLiving Platform,Ltd.
TimelineThe spacing between the points is proportional to the actual number of days.
Target company
Dispensing Pharmacy Business
Location Asahikawa, HokkaidoShare capital ¥10 millionDate of incorporation June 2017
Consideration and expenses
Goodwill amountPositive goodwill is expected to arise, but the amount has not yet been finalized.
Goodwill is the amount paid in excess of the acquired company's net assets.Impact on Business Performance
The impact on financial results for the fiscal year ending March 2026 is immaterial.
| Item | Details |
|---|---|
| Transaction name | This absorption-type company split (business acquisition) |
| Counterparty name | ポポヤクコーポレーション株式会社 |
| Name of the Subject Company | ポポヤクコーポレーション株式会社 |
| Business Description of the Subject Company | Dispensing Pharmacy Business |
| Location of the Subject Company | Asahikawa, Hokkaido |
| Capital Stock of the Subject Company | ¥10 million |
| Date of Establishment of the Subject Company | June 2017 |
| Goodwill amount | Positive goodwill is expected to arise, but the amount has not yet been finalized. |
| Impact on Business Performance | The impact on financial results for the fiscal year ending March 2026 is immaterial. |
| Contract Date | 27 March 2026 |
| Execution Date / Effective Date | 1 April 2026 (completed) |
Items this document does not state (21)
Net Sales of the Subject CompanyOperating Profit of the Subject CompanyNet Income of the Subject CompanyNet Assets of the Subject CompanyAcquisition priceExpenses other than the acquisition priceType of ConsiderationMerger ratio/share exchange ratioTender offer priceMinimum number of shares to be purchasedTender offer periodNumber of shares acquiredVoting rights ownership percentageFunding arrangementsAmount of extraordinary income (loss)Date of board resolutionValuation methodologyIndependent valuation institutionSpecial CommitteeConditions Precedent to ExecutionManagement structure after acquisition
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The completion of the transaction has been disclosed, but no reason for the business acquisition is provided.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.